Concepedia

Priscilla Merriam

PM

Statistics

Publications

18

Citations

1.7K

H-Index

16

Active since

2001

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Brigham and Women's Hospital

Memorial Sloan Kettering Cancer Center

Priscilla Merriam is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and pathology.

ORCID

Top concepts

Publications per year

2001–2024

18

Publications

18

Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas

Suzanne George, Priscilla Merriam, Robert G. Maki et al. · Journal of Clinical Oncology · 2009 · 315 citations · Full text

, , +12

Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy

Rocio García‐Carbonero, Jeff Supko, Judith Manola et al. · Journal of Clinical Oncology · 2004 · 292 citations · Full text

The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research

Corrie Painter, Esha Jain, Brett N. Tomson et al. · Nature Medicine · 2020 · 262 citations

, , +9

Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

Eytan Ben‐Ami, Constance M. Barysauskas, Sarah Solomon et al. · Cancer · 2017 · 215 citations · Full text

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor et al. · New England Journal of Medicine · 2023 · 213 citations · Full text

1–5 of 18